The legislation aims to reduce US dependence on foreign labs and suppliers. (Photo Source: Freepik) Show Quick Read Summary is AI Generated. Newsroom Reviewed

The US Senate on Friday passed the National Defense Authorisation Act which embedded an amended version of US Biosecure Act. The Biosecure Act aims to limit investment in sensitive Chinese industries.

The act mainly aims to safeguard American biotech and health data from foreign threats, particularly those posed by Chinese companies. The legislation aims to reduce US dependence on foreign labs and suppliers.

The Biosecure Act was first introduced in the US Senate in December 2023 and in the House in January 2024. It gained momentum and was passed by the House with bipartisan support in September 2024. However, the Senate bloc

See Full Page